lipoma: A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue.
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_LIPO_SKIN_HEADFACENECK
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2875 |
4. Check minimum number of eventsNone |
2875 |
5. Include endpointsNone |
2875 |
6. Filter based on genotype QC (FinnGen only) |
2594 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D17
- Name in latin
- Neoplasma benignum lipomatosum cutis capitis/colli/nuchae
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 17408 | 7349 | 9961 |
| Only index persons | 16692 | 7138 | 9554 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.25 | 0.21 | 0.28 |
| Only index persons | 0.32 | 0.26 | 0.36 |
| Median age at first event (years) | |||
| Whole population | 53.92 | 54.12 | 53.85 |
| Only index persons | 53.72 | 53.94 | 53.56 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2594 | 1204 | 1390 |
| Unadjusted period prevalence (%) | 0.54 | 0.43 | 0.64 |
| Median age at first event (years) | 57.02 | 54.98 | 58.78 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2693
- Matched controls
- 26930
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
11.2
307.7
393
403
D17.0
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
+∞
307.7
2693
47
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
6.9
307.7
583
1035
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
13.5
307.7
1088
1288
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
10.3
198.5
230
242
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.2
157.9
290
517
D17.9
ICD-10 Finland
Benign lipomatous neoplasm, unspecified
12.3
157.7
160
138
D17
ICD-10 Finland
Benign lipomatous neoplasm
11.7
145.5
152
137
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
46.5
115.6
68
15
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
6.8
84.1
135
208
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
5.9
77.8
144
256
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
8.1
72.2
98
125
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.2
59.2
162
401
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
15.0
56.3
50
34
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.6
46.8
306
1280
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.2
45.8
126
313
L72.1
ICD-10 Finland
Trichilemmal cyst
2.7
44.1
262
1044
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
4.8
40.8
93
199
S04
ICPC
Lump/swelling localized
2.3
39.9
354
1693
S78
ICPC
Lipoma
7.8
37.4
52
68
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
32.9
203
822
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.4
31.4
79
183
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.8
30.8
95
256
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.2
30.0
123
399
WX110
NOMESCO Finland
Infiltration anesthesia
1.7
29.9
1932
16269
D21.0
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of head, face and neck
10.1
29.2
33
33
S18
ICPC
Laceration/cut
1.6
26.9
1315
10250
QX3HE, ,
SPAT
3.6
24.8
82
232
TQW99
NOMESCO Finland
Other minor procedure on skin
2.4
23.9
164
698
SPAT1153
SPAT
Removal of sutures
1.6
23.8
851
6141
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
5.9
20.9
37
63
N02AX02
ATC
tramadol; systemic, rectal
1.4
18.8
1140
9060
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.6
18.2
109
435
ZXA00
NOMESCO Finland
Right side
1.5
17.9
671
4840
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
16.8
924
7170
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.1
16.5
67
217
M03BX02
ATC
tizanidine; oral
1.4
16.3
1600
13711
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
15.8
1135
9204
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.6
15.4
88
344
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
4.9
15.2
33
68
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
15.2
644
4739
ZXD20
NOMESCO Finland
Day surgery
1.7
15.1
316
1982
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
15.1
2356
21863
D17.7
ICD-10 Finland
Benign lipomatous neoplasm of other sites
10.9
15.0
28
26
ZXA05
NOMESCO Finland
Left side
1.5
14.8
606
4425
N02BE01
ATC
paracetamol; systemic, rectal
1.6
14.6
2351
21835
J01DB01
ATC
cefalexin; oral
1.5
13.8
2136
19503
M79.6
ICD-10 Finland
Pain in limb
1.4
13.6
1104
9062
B01AB05
ATC
enoxaparin; parenteral
1.4
12.5
771
6038
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
12.3
1809
16162
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
12.0
1379
11855
M54.5
ICD-10 Finland
Low back pain
1.4
11.9
899
7262
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
11.6
1096
9140
UJF32
NOMESCO Finland
Coloscopy
1.4
11.5
647
4978
R02
ICPC
Shortness of breath/dyspnoea
1.5
11.1
336
2294
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
11.1
854
6898
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
11.1
541
4058
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
10.9
266
1732
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
10.8
879
7151
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
15.5
10.8
17
11
ENB99
NOMESCO Finland
Other excision of pharynx and adjacent structures
28.1
10.7
14
5
ZXE00
NOMESCO Finland
One hour or less
1.3
10.7
899
7349
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
10.5
1578
13966
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
10.4
1619
14390
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
10.3
997
8304
SFA20
NOMESCO Finland
Two-surface restoration
1.3
10.3
1451
12718
R03AC02
ATC
salbutamol; inhalant
1.3
10.3
1324
11464
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
4.4
10.3
25
57
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
4.7
10.2
23
49
R01AD09
ATC
mometasone; nasal
1.3
10.2
1062
8934
A98
ICPC
Health maint/preventive medicine
1.8
10.0
2572
24779
KMAK, ,
NOMESCO Finland
1.3
9.9
1205
10337
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
9.9
462
3432
C08CA01
ATC
amlodipine; oral
1.3
9.9
965
8037
R51.80
ICD-10 Finland
Headache
1.5
9.8
350
2471
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
9.6
439
3248
Z2221
NOMESCO Finland
Medical doctor
1.4
9.5
612
4793
WX002
NOMESCO Finland
Sedation and analgesia
1.4
9.4
454
3391
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
9.3
554
4284
S29
ICPC
Skin symptom/complaint other
1.4
9.2
482
3646
D23.4
ICD-10 Finland
Benign neoplasm: Skin of scalp and neck
2.9
9.2
41
141
G47.3
ICD-10 Finland
Sleep apnoea
1.3
9.1
611
4812
QBJ00
NOMESCO Finland
Liposuction in trunk
4.8
9.1
20
42
N03AX12
ATC
[U] gabapentin; oral
1.4
9.0
386
2823
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
8.9
1103
9438
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
8.9
888
7395
SPAT1263
SPAT
Sampling
1.3
8.8
945
7938
M01AH05
ATC
etoricoxib; oral
1.3
8.8
1567
14024
R22
ICD-10 Finland
Localized swelling, mass and lump of skin and subcutaneous tissue
2.3
8.8
65
288
WX704
NOMESCO Finland
Intubation
1.6
8.6
196
1254
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.7
8.5
161
982
P01AB01
ATC
metronidazole; oral, rectal
1.3
8.5
917
7697
E66.8
ICD-10 Finland
Other obesity
1.8
8.5
130
748
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.7
8.4
153
924
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
8.4
437
3303
SFA10
NOMESCO Finland
One-surface restoration
1.3
8.4
1331
11718
J01MA02
ATC
ciprofloxacin; systemic
1.3
8.4
929
7827
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
8.3
532
4151
R42
ICD-10 Finland
Dizziness and giddiness
1.4
8.2
519
4042
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
8.1
570
4509
A02BC02
ATC
pantoprazole; systemic
1.3
8.1
1723
15677
J01DA01
ATC
[U] cefalexin
1.3
8.1
1475
13173
J01FF01
ATC
clindamycin; systemic
1.3
8.1
641
5158
R01AD08
ATC
fluticasone; nasal
1.3
7.9
642
5181
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
7.8
7.9
17
22
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
7.8
435
3319
D01
ICPC
Abdominal pain/cramps general
1.5
7.8
264
1844
R01AD58
ATC
fluticasone, combinations; nasal
1.3
7.8
546
4316
R21
ICPC
Throat symptom/complaint
1.4
7.8
411
3112
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
7.7
141
854
M04AA01
ATC
allopurinol; systemic
1.4
7.7
313
2265
N03AX16
ATC
[U] pregabalin
1.3
7.6
534
4224
SPAT1301
SPAT
No procedures
1.3
7.5
686
5621
EP1AE, ,
SPAT
2.3
7.5
56
250
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.5
654
5330
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.8
7.4
116
674
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
6.0
7.4
19
32
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
7.3
250
1748
J01AA02
ATC
doxycycline; systemic
1.3
7.3
1952
18125
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.3
153
960
J01FA06
ATC
roxithromycin; oral
1.3
7.3
915
7794
D11
ICPC
Diarrhoea
1.5
7.3
250
1751
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.3
7.3
716
5920
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
7.3
160
1017
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.0
7.2
74
374
VALMI, ,
NOMESCO Finland
1.3
7.1
513
4065
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.1
892
7592
G44.2
ICD-10 Finland
Tension-type headache
1.4
7.1
290
2100
S10
ICPC
Boil/carbuncle
1.6
7.1
141
874
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
4.1
7.1
19
47
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
7.1
1236
10920
L01
ICPC
Neck symptom/complaint
1.4
7.0
361
2717
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
7.0
634
5186
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.0
6.9
68
339
A02BC05
ATC
esomeprazole; systemic
1.3
6.9
956
8222
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.4
6.9
343
2569
SDA03
NOMESCO Finland
Periodontal treatment
1.3
6.8
948
8154
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.3
6.8
48
210
M25.5
ICD-10 Finland
Pain in joint
1.3
6.8
780
6566
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
3.5
6.7
22
63
L72.0
ICD-10 Finland
Epidermal cyst
2.6
6.7
37
144
QX2XE, ,
SPAT
3.0
6.7
29
99
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
6.6
801
6775
S21
ICPC
Skin texture symptom/complaint
1.4
6.6
343
2587
QAE15
NOMESCO Finland
Excision of other superficial lesion of skin from head and neck
8.7
6.5
13
15
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
6.5
406
3148
H02AB06
ATC
prednisolone; systemic
1.2
6.5
1125
9901
H01
ICPC
Ear pain/earache
1.4
6.5
238
1690
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
6.4
518
4165
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.4
6.4
249
1786
M79.1
ICD-10 Finland
Myalgia
1.4
6.4
331
2494
L16
ICPC
Ankle symptom/complaint
1.4
6.4
267
1941
Z3226
NOMESCO Finland
Physiotherapist
1.3
6.4
395
3062
Z00.0
ICD-10 Finland
General medical examination
1.3
6.3
431
3387
WX402
NOMESCO Finland
General anaesthesia
1.3
6.3
520
4193
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
1.7
6.3
121
744
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
6.3
649
5384
J01DA09
ATC
[U] cefadroxil
1.3
6.2
577
4722
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.2
1401
12648
A02BC01
ATC
omeprazole; systemic
1.3
6.2
592
4863
R06AE07
ATC
cetirizine; oral
1.2
6.2
971
8442
D07AC13
ATC
mometasone; topical
1.3
6.2
651
5412
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.4
6.2
241
1730
SPAT1325
SPAT
Vaccination
1.3
6.2
710
5964
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
6.2
676
5646
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
6.1
1084
9540
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
1.9
6.1
67
348
ELB40
NOMESCO Finland
Partial parotidectomy
2.6
6.1
34
133
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.6
6.1
34
133
Z01.2
ICD-10 Finland
Dental examination
1.2
6.1
1066
9369
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.5
6.1
216
1524
E88.2
ICD-10 Finland
Lipomatosis, not elsewhere classified
12.5
6.1
10
8
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
6.1
581
4774
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
6.1
498
4013
M10.9
ICD-10 Finland
Gout, unspecified
1.5
6.1
172
1160
R74
ICPC
Upper respiratory infection acute
1.3
6.0
667
5575
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
5.2
6.0
17
33
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
6.0
230
1646
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
2487
23174
1.96
19.14
17.8
16.8
24.72
24.78
mg/l
0.03
2103
19203
2334
21551
1.62
15.95
5.6
5.2
1.87
1.92
mu/l
1.18
2182
19957
1992
17854
1.44
15.09
4.5
4.4
11.19
12.09
mm/h
2.24
1880
16735
2530
23973
1.91
14.59
21.4
20.1
3.98
3.98
mmol/l
0.38
2488
23513
2593
24802
2.22
14.28
23.8
21.9
79.44
79.59
umol/l
0.08
2561
24549
2524
23919
1.88
14.24
21.1
19.9
139.93
139.71
mmol/l
4.80
2487
23493
2401
22456
1.64
14.01
7.4
6.6
39.85
39.57
mmol/mol
0.84
2261
21097
2624
25247
2.54
13.84
27.3
25.5
250.90
247.39
e9/l
2.11
2573
24775
2624
25252
2.53
13.74
27.2
25.4
90.92
91.29
fl
4.41
2600
25002
2624
25255
2.52
13.68
27.8
26.0
41.04
41.01
%
0.03
2600
24990
2624
25255
2.52
13.68
27.3
25.4
4.56
4.51
e12/l
5.97
2568
24705
2624
25259
2.52
13.60
27.4
25.5
6.76
6.76
e9/l
0.01
2568
24706
2624
25260
2.51
13.58
27.5
25.6
137.24
136.28
g/l
2.79
2602
25015
2574
24621
2.03
13.06
13.5
12.6
27.46
27.23
u/l
0.20
2505
23976
1345
11440
1.35
12.98
2.7
2.9
—
—
estimate
—
0
0
2418
22732
1.62
12.87
5.8
5.3
6.05
6.00
mmol/l
1.31
2251
20953
2497
23682
1.75
12.71
6.4
6.0
2.69
2.69
mmol/l
0.07
2344
22138
2462
23376
1.62
11.03
5.6
5.3
4.57
4.60
mmol/l
0.93
2325
21934
2450
23243
1.60
10.92
5.4
5.2
1.41
1.43
mmol/l
2.75
2294
21677
2047
18795
1.37
10.73
8.8
8.6
78.79
79.19
u/l
0.11
1954
17933
1459
12765
1.31
10.66
4.1
3.9
11.11
5.74
estimate
0.29
257
2708
1979
18084
1.36
10.63
4.5
4.3
14.91
14.81
pmol/l
0.98
1838
16618
1442
12620
1.31
10.39
4.1
3.9
0.00
0.00
estimate
0.50
250
2652
1722
15451
1.32
10.28
4.9
4.6
2278.60
1559.44
e6/l
0.13
20
228
1459
12809
1.30
10.18
6.0
6.6
1.93
1.93
e9/l
0.03
1281
11289
1436
12586
1.30
10.12
6.0
6.5
0.04
0.04
e9/l
0.18
1213
10829
1461
12839
1.30
10.07
4.1
3.9
1.27
0.01
estimate
0.50
240
2494
1474
12975
1.30
10.00
6.1
6.7
0.20
0.19
e9/l
0.74
1287
11339
1801
16318
1.31
9.69
3.4
3.4
54.01
51.35
u/l
0.41
1692
15347
1493
13199
1.29
9.64
6.7
6.9
11.70
11.72
umol/l
0.02
1433
12633
1625
14624
1.28
8.66
5.5
5.5
6.83
6.77
mmol/l
0.48
1540
13958
1415
12526
1.27
8.59
7.3
7.8
1.21
1.21
mmol/l
0.98
1272
10862
673
5428
1.32
8.41
1.8
1.8
1.03
1.24
mg/l
1.35
530
4208
2078
19403
1.31
7.78
23.5
21.5
332.77
332.66
g/l
0.22
2070
19305
1558
14056
1.26
7.64
9.6
10.0
4.16
4.16
e9/l
0.04
1343
12229
1277
11281
1.25
7.46
6.5
7.1
1.21
1.21
mmol/l
0.83
1196
10460
112
642
1.78
7.45
1.2
1.2
—
—
—
0
0
1013
8727
1.26
7.34
4.4
4.2
6.30
8.49
mg/mmol
1.44
671
5535
1325
11796
1.24
7.07
6.1
6.8
27.24
27.46
%
0.29
1236
11208
607
4934
1.30
7.00
4.1
3.9
287.94
450.01
ng/l
1.07
485
3944
800
6744
1.26
6.87
3.1
3.0
0.07
0.01
0.36
14
150
2335
22269
1.37
6.86
4.6
4.4
1.33
1.32
mmol/l
0.41
2170
20587
1034
9010
1.24
6.56
4.0
3.5
7.76
7.78
mmol/l
0.05
890
7639
947
8193
1.24
6.37
3.7
3.4
48.69
72.81
e6/l
0.89
743
6298
1237
11010
1.23
6.36
2.2
2.1
98.10
95.64
pmol/l
0.99
669
5963
1292
11580
1.22
6.12
5.9
6.6
57.65
57.48
%
0.20
1221
11096
674
5636
1.26
6.08
4.7
4.0
1.02
1.29
kg/l
0.50
461
3751
465
3711
1.31
6.08
1.5
1.5
—
—
—
0
0
972
8473
1.23
6.01
3.4
3.3
33.28
35.93
u/l
0.53
914
8008
264
1937
1.40
5.99
1.5
1.5
—
—
—
0
0
921
7997
1.23
5.88
2.8
2.7
60.20
69.91
u/l
0.43
852
7443
793
6778
1.24
5.86
3.1
2.9
354.74
348.64
umol/l
0.99
713
6007
1221
10931
1.21
5.71
2.5
2.4
75.95
77.35
nmol/l
1.04
1103
9916
90
531
1.72
5.50
6.0
8.5
105.60
105.31
mmol/l
0.20
83
469
894
7792
1.22
5.40
4.8
4.4
21.80
21.65
%
0.11
454
3745
376
2962
1.31
5.38
2.6
2.5
136.76
143.78
ug/g
0.16
303
2392
1092
9709
1.21
5.38
5.7
5.4
2.78
2.65
ug/l
0.12
1003
8834
1081
9605
1.21
5.35
4.2
3.8
0.03
0.08
estimate
0.50
202
2203
263
1967
1.37
5.33
2.8
3.0
176.31
192.53
ng/l
0.31
241
1802
225
1640
1.41
5.32
5.5
7.3
24.55
24.44
mmol/l
0.15
216
1571
2358
22682
1.32
5.24
17.3
16.3
80.18
80.37
ml/min/173m2
0.19
2190
21117
170
1184
1.47
5.15
4.9
5.8
1.67
1.60
%
0.38
161
1117
157
1082
1.48
5.02
5.1
6.1
0.91
0.87
%
0.77
148
1017
1291
11715
1.20
4.97
17.1
15.4
1.27
1.26
inr
0.43
1098
9763
1239
11207
1.20
4.93
5.5
5.3
35.77
35.62
g/l
0.44
1173
10556
809
7037
1.21
4.89
3.7
3.3
0.41
0.41
e6/l
0.00
601
5192
34
152
2.25
4.66
1.4
1.4
1.38
1.14
nmol/l
0.77
27
110
159
1118
1.45
4.61
1.1
1.0
—
—
—
0
0
2034
19315
1.22
4.53
22.0
20.7
13.64
13.65
%
0.16
2017
19058
528
4429
1.24
4.50
3.3
3.0
1.20
0.99
e6/l
0.65
296
2373
736
6401
1.21
4.38
4.5
4.3
91.20
89.07
%
1.54
716
6279
659
5684
1.21
4.26
2.7
2.7
4.66
5.05
e6/l
0.37
603
5202
888
7874
1.19
4.25
2.3
2.2
190.60
231.08
u/l
0.98
846
7465
56
317
1.78
4.04
1.4
1.4
272.55
315.94
pmol/l
0.54
49
270
209
1581
1.35
3.99
7.7
11.7
16.32
16.07
%
0.66
202
1525
329
2654
1.27
3.93
7.8
9.7
124.04
122.15
g/l
0.94
321
2594
60
350
1.73
3.92
1.5
1.3
0.55
5.69
nmol/l
0.51
60
336
377
3115
1.24
3.67
7.1
8.8
1.16
0.89
mmol/l
0.81
317
2569
1197
10987
1.16
3.58
3.0
3.1
122.56
141.58
ug/l
2.19
1131
10281
344
2826
1.25
3.53
7.4
9.1
95.03
95.65
%
0.75
332
2733
609
5303
1.19
3.48
1.4
1.3
2.07
1.59
u/ml
0.27
172
1452
51
296
1.74
3.43
1.7
1.3
—
—
—
0
0
267
2150
1.27
3.26
2.7
2.5
0.42
0.48
e6/l
0.19
257
2051
375
3137
1.23
3.26
7.2
8.8
5.16
5.11
kpa
0.51
364
3027
375
3138
1.23
3.25
7.2
8.8
12.18
12.20
kpa
0.02
363
3030
185
1420
1.33
3.24
3.1
3.6
4.56
4.49
pmol/l
0.49
165
1264
44
249
1.78
3.24
1.2
1.4
184396.03
72993.79
e6/l
0.51
31
173
473
4056
1.20
3.19
3.5
3.2
2.88
1.94
e6/l
1.09
240
1991
159
1198
1.35
3.17
4.1
3.5
1.02
1.02
ratio
0.30
143
1098
694
6176
1.17
3.02
2.3
2.5
—
—
—
0
0
518
4505
1.19
2.98
1.4
1.3
20.00
33.18
iu/ml
5.29
161
1384
1487
13981
1.14
2.94
2.9
2.8
—
—
—
0
0
470
4059
1.19
2.93
1.7
1.7
1083.90
1171.84
nmol/l
1.47
383
3112
1133
10470
1.14
2.89
2.0
2.0
1.39
1.38
mmol/l
0.04
982
8799
51
314
1.64
2.82
1.5
1.3
0.18
0.24
nmol/l
0.48
36
252
44
263
1.68
2.73
1.4
1.3
24.93
28.75
u/l
0.33
35
212
185
1468
1.28
2.59
1.2
1.2
153.13
149.07
u/ml
0.04
73
529
283
2371
1.22
2.45
2.7
2.3
357.86
378.24
nmol/l
1.07
264
2211
340
2906
1.19
2.39
2.7
2.9
8.45
8.17
umol/l
0.08
302
2590
477
4195
1.17
2.39
1.4
1.3
4.73
11.27
u/ml
3.66
181
1632
249
2070
1.22
2.34
2.8
2.7
66.10
66.31
ml/min/173m2
0.03
110
877
0
61
0.00
2.23
0.0
1.2
—
—
—
0
0
28
478
0.58
2.20
1.1
1.9
—
—
—
0
0
834
7668
1.13
2.17
3.1
3.2
1261.71
1284.96
ng/l
0.07
730
6602
644
5842
1.13
2.07
3.3
3.2
0.75
0.75
ug/l
0.02
439
3777
112
860
1.32
2.06
1.5
1.6
15.24
15.69
u/ml
0.04
16
192
743
6805
1.13
2.05
3.7
3.4
0.15
0.14
estimate
0.02
205
2079
776
7126
1.12
2.04
1.7
1.7
19.84
20.11
nmol/l
0.20
671
6047
332
2877
1.18
2.01
7.4
6.8
—
—
—
0
0
219
2600
0.83
1.95
3.5
3.5
—
—
—
0
0
343
2989
1.17
1.95
1.8
1.9
—
—
—
0
0
201
1670
1.22
1.94
2.6
3.2
132.95
129.42
g/l
1.38
191
1625
307
2655
1.18
1.92
3.8
4.4
98.51
19.47
ug/l
0.44
244
2171
704
6452
1.12
1.91
2.4
2.3
2.75
2.83
mg/l
0.44
616
5582
117
916
1.29
1.89
1.4
1.4
32.67
28.86
iu/l
0.56
104
782
307
2659
1.17
1.88
3.7
3.7
5.86
5.82
kpa
0.36
297
2592
770
7099
1.12
1.88
4.4
4.0
0.00
0.00
estimate
1.54
236
2443
299
2586
1.18
1.87
3.7
3.7
1.99
1.83
mmol/l
0.30
255
2253
545
4926
1.13
1.85
3.2
3.1
2.44
2.45
mmol/l
0.83
484
4443
1145
10793
1.11
1.83
10.9
11.9
0.00
0.00
e9/l
1.47
917
8851
360
3166
1.16
1.82
1.8
1.8
—
—
—
0
0
26
153
1.71
1.79
3.3
1.7
—
—
—
0
0
217
1833
1.20
1.79
1.5
1.7
—
—
—
0
0
916
8550
1.11
1.76
3.8
3.6
2.35
2.35
mmol/l
0.63
836
7808
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
280
2432
1.17
1.68
3.1
2.5
34.28
58.39
u/l
0.65
233
2070
32
203
1.58
1.68
4.5
5.4
453.09
43.90
u/ml
—
9
60
470
4238
1.13
1.66
1.9
2.0
—
—
—
0
0
21
354
0.59
1.64
1.0
1.7
—
—
—
0
0
11
49
2.25
1.63
1.0
1.1
—
—
—
0
0
279
2433
1.16
1.60
7.1
8.6
1.41
1.36
mmol/l
0.33
274
2393
440
3967
1.13
1.56
2.4
2.1
30.33
29.74
s
1.01
425
3864
203
1731
1.19
1.54
1.6
1.9
—
—
—
0
0
8
33
2.43
1.53
2.3
1.7
—
—
—
0
0
12
58
2.07
1.49
1.2
1.1
254.71
284.12
pmol/l
—
7
42
48
342
1.41
1.49
2.0
1.9
15.01
24.78
ug/l
1.86
48
336
221
1906
1.17
1.47
4.3
4.1
85.88
93.00
ng/l
0.72
190
1680
147
1224
1.21
1.45
1.9
2.2
0.00
0.69
estimate
0.51
44
366
221
1909
1.17
1.45
1.8
1.9
—
—
—
0
0
96
763
1.27
1.44
1.4
1.5
312.64
270.59
ug/g
0.87
47
469
25
156
1.61
1.43
2.6
2.8
34.62
40.92
%
0.82
17
81
37
253
1.47
1.43
1.1
1.0
0.27
0.29
u/ml
0.02
11
88
50
363
1.38
1.41
1.0
1.1
2.49
4.46
u/ml
1.01
24
180
28
182
1.54
1.37
1.1
1.3
9.00
9.30
mmol/l
0.14
28
176
47
345
1.37
1.26
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
104
851
1.23
1.25
2.8
3.2
0.36
0.34
iu/ml
0.21
63
452
24
155
1.55
1.23
1.1
1.1
6.56
9.47
iu/ml
—
7
52
15
85
1.77
1.23
1.7
3.1
12.17
10.17
kpa
0.58
15
85
15
85
1.77
1.23
1.7
3.1
5.00
4.85
kpa
0.25
15
85
77
612
1.27
1.20
2.2
2.4
126.16
129.74
g/l
0.59
56
483
26
173
1.51
1.18
1.6
2.3
—
—
—
0
0
1004
9557
1.08
1.17
4.0
3.9
50.67
60.60
ng/l
0.25
696
6894
22
141
1.56
1.17
1.7
2.1
105.73
99.89
%
0.40
22
135
55
422
1.31
1.13
1.1
1.1
1.32
1.72
u/ml
0.21
25
229
84
682
1.24
1.11
1.5
1.6
29070.05
13500.17
e6/l
0.51
66
467
49
371
1.33
1.11
1.6
1.6
—
—
—
0
0
47
354
1.33
1.10
1.0
1.1
0.47
1.46
u/ml
1.55
17
147
78
629
1.25
1.10
1.6
2.0
2.88
13.19
iu/l
0.59
34
255
115
966
1.20
1.10
2.6
2.3
520.61
477.46
ug/l
0.09
109
921
87
712
1.23
1.08
1.3
1.4
—
—
—
0
0
17
267
0.63
1.07
1.2
1.9
—
—
—
0
0
51
391
1.31
1.07
1.1
1.1
17.70
19.30
au/ml
0.05
13
102
81
664
1.23
1.00
1.2
1.3
—
—
—
0
0
24
345
0.69
1.00
1.0
1.8
—
—
—
0
0
17
107
1.59
0.99
1.1
1.1
194.55
191.95
iu/ml
0.01
17
107
550
5144
1.09
0.99
1.8
1.7
36688066.56
33139965.41
pmol/l
0.04
477
4300
114
968
1.19
0.99
3.9
3.5
278.32
2500.63
u/ml
1.13
102
850
509
4746
1.09
0.99
1.5
1.5
2.39
2.53
g/l
1.06
313
2989
7
36
1.95
0.97
1.0
1.2
—
—
—
0
0
22
317
0.69
0.94
1.5
1.4
1840.76
4471.69
e6/l
0.43
17
218
33
443
0.74
0.93
1.6
1.6
972.97
1007.43
mu/l
0.09
25
358
20
292
0.68
0.92
1.2
1.8
—
—
—
0
0
15
232
0.64
0.91
1.0
1.0
—
—
—
0
0
41
525
0.78
0.85
1.0
1.2
—
45.96
—
0
5
67
551
1.22
0.84
2.9
1.7
0.86
0.87
nmol/l
0.07
55
470
74
615
1.21
0.84
2.1
2.4
85.94
123.72
ug/min
0.43
44
380
73
874
0.83
0.83
1.4
1.7
3.46
4.90
mg/l
0.95
57
654
85
717
1.19
0.83
1.3
1.4
—
—
—
0
0
140
1588
0.88
0.82
2.1
1.9
1.17
1.36
g/l
0.80
134
1466
12
73
1.65
0.81
1.0
1.5
86.67
89.36
%
—
6
45
12
73
1.65
0.81
1.0
1.2
76.83
88.14
%
—
6
44
189
1696
1.12
0.81
2.4
2.5
10.93
19.47
au/ml
2.21
17
167
36
276
1.31
0.80
1.1
1.1
5.37
3.52
u/ml
0.23
15
112
37
285
1.30
0.80
3.2
6.1
7.74
7.37
mmol/l
0.26
32
241
176
1574
1.13
0.80
1.7
1.7
—
—
—
0
0
280
2569
1.10
0.80
2.3
2.4
13.57
13.64
nmol/l
0.05
252
2325
14
212
0.66
0.80
1.0
1.7
—
—
—
0
0
10
58
1.73
0.79
1.0
1.3
—
—
—
0
0
78
656
1.19
0.79
1.4
1.4
8.87
9.11
u/l
0.06
65
531
87
739
1.18
0.79
2.0
2.5
196.56
193.93
%
0.09
80
707
5
99
0.50
0.77
1.2
1.2
—
—
—
0
0
5
100
0.50
0.77
3.0
2.9
34.60
30.22
umol/l
—
5
70
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
19
268
0.71
0.76
1.8
1.5
45.23
59.74
ug/l
0.62
14
216
468
4402
1.08
0.75
3.2
3.6
0.82
0.82
mmol/l
0.36
450
4180
21
149
1.41
0.75
1.3
1.9
64.63
117.96
ng/l
7.15
21
149
173
1553
1.12
0.75
1.3
1.3
62.13
57.47
au/ml
0.09
12
118
26
192
1.36
0.75
1.2
1.1
108.92
105.69
pmol/l
0.19
26
192
5
24
2.09
0.74
1.2
1.3
11.80
13.96
u/l
—
5
24
196
1777
1.11
0.72
9.2
11.0
0.63
0.63
%
0.06
196
1766
11
171
0.64
0.72
1.1
1.2
—
—
—
0
0
22
299
0.73
0.72
1.4
1.5
—
—
—
0
0
237
2171
1.10
0.71
2.4
2.3
8.96
7.90
ug/l
0.23
215
1954
11
170
0.65
0.70
1.1
1.2
—
—
—
0
0
109
1241
0.87
0.70
1.7
1.8
1.56
1.54
g/l
0.10
98
1083
175
1580
1.12
0.70
1.3
1.3
233.31
210.65
u/ml
0.14
166
1463
17
118
1.44
0.69
1.3
1.7
—
—
—
0
0
11
69
1.60
0.68
1.3
1.3
62.86
56.29
ug/l
—
5
28
85
733
1.16
0.68
1.8
1.6
1.25
1.19
g/l
1.02
80
697
183
2013
0.90
0.67
2.8
3.0
10.63
10.64
g/l
0.01
177
1860
11
168
0.65
0.67
1.2
1.6
—
—
—
0
0
18
249
0.72
0.66
1.7
1.4
0.96
1.16
ratio
0.35
11
157
18
249
0.72
0.66
1.7
1.4
0.85
0.97
ratio
1.05
11
157
18
249
0.72
0.66
1.7
1.4
0.99
1.18
ratio
0.55
11
157
5
28
1.79
0.66
2.2
2.8
0.40
0.43
u/field
—
5
28
18
247
0.73
0.64
1.7
1.4
—
—
—
0
0
66
561
1.18
0.63
1.6
1.6
—
—
—
0
0
163
1476
1.11
0.63
3.4
3.6
1.70
1.89
mmol/l
0.32
120
1092
109
964
1.14
0.63
2.0
2.0
—
—
—
0
0
18
246
0.73
0.63
1.8
2.7
—
—
—
0
0
65
553
1.18
0.62
1.2
1.2
52.64
50.03
u/ml
—
9
58
100
880
1.14
0.62
1.9
1.8
—
—
—
0
0
264
2450
1.09
0.62
7.3
8.0
10.15
10.06
mmol/l
0.08
254
2358
102
899
1.14
0.62
1.7
1.9
—
—
—
0
0
5
30
1.67
0.61
1.2
1.0
7.82
7.20
u/ml
—
5
30
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
199
1827
1.10
0.60
9.1
10.9
92.91
93.96
%
1.08
199
1819
8
52
1.54
0.59
1.5
1.2
—
—
—
0
0
8
52
1.54
0.59
1.3
1.5
—
—
—
0
0
11
162
0.68
0.58
1.2
1.6
—
—
—
0
0
8
53
1.51
0.58
1.0
1.6
—
—
—
0
0
6
35
1.72
0.57
1.0
1.0
—
—
—
0
0
5
87
0.57
0.56
1.2
1.1
—
—
—
0
0
41
338
1.22
0.56
1.0
1.1
0.70
1.71
u/ml
1.11
19
168
15
107
1.40
0.55
1.1
1.4
—
—
—
0
0
15
107
1.40
0.55
1.1
1.4
—
—
—
0
0
8
124
0.64
0.54
1.1
1.3
28.50
28.64
umol/l
—
8
114
427
4057
1.06
0.54
2.6
2.7
2.39
2.29
g/l
3.54
410
3778
8
125
0.64
0.54
2.1
3.5
1.88
1.20
%
—
8
125
8
126
0.63
0.54
1.7
1.6
4.38
3.95
u/field
—
8
96
39
470
0.83
0.53
1.3
1.4
155.40
156.75
au/ml
—
10
135
55
469
1.18
0.53
4.6
3.4
0.82
0.82
nmol/l
0.01
48
383
55
470
1.17
0.52
1.3
1.3
—
—
—
0
0
55
470
1.17
0.52
1.3
1.3
—
—
—
0
0
6
96
0.62
0.52
1.7
2.2
327.33
147.06
nmol/l
—
6
85
6
40
1.50
0.51
1.8
2.1
—
—
—
0
0
41
489
0.84
0.51
1.1
1.2
342.32
273.80
u/ml
0.51
28
293
114
1028
1.11
0.51
1.4
1.3
—
—
—
0
0
21
270
0.78
0.51
1.5
1.4
10314.42
100320.43
e6/l
2.00
12
150
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
11
75
1.47
0.50
1.0
1.2
136.18
104.77
%
1.71
11
70
19
144
1.32
0.50
1.1
1.4
—
—
—
0
0
6
41
1.46
0.50
1.8
2.1
—
—
—
0
0
189
1751
1.09
0.49
3.7
3.7
5.16
5.16
kpa
0.02
181
1691
14
101
1.39
0.49
1.1
1.1
—
—
—
0
0
28
225
1.25
0.49
1.3
1.5
32.71
29.75
%
0.18
17
140
60
520
1.16
0.49
1.3
1.5
—
—
—
0
0
128
1165
1.10
0.49
2.7
3.4
25.32
25.32
mmol/l
0.00
121
1126
88
784
1.13
0.49
2.0
1.9
212.53
208.63
pmol/l
0.18
83
741
252
2363
1.07
0.49
2.0
2.8
68.82
70.73
e9/l
0.44
189
1748
82
728
1.13
0.48
3.2
4.1
3.87
3.91
mmol/l
0.35
82
722
7
46
1.52
0.48
5.0
8.2
11.40
10.46
%
—
7
46
69
783
0.88
0.47
3.3
2.4
0.00
0.00
g/l
-0.00
63
688
16
211
0.76
0.47
1.6
1.6
—
—
—
0
0
19
146
1.30
0.47
1.1
1.4
—
—
—
0
0
90
806
1.12
0.47
1.9
2.2
93.52
92.29
%
0.18
85
783
7
48
1.46
0.46
1.0
1.3
—
—
—
0
0
36
300
1.20
0.46
1.1
1.1
1.75
1.84
u/ml
0.03
17
145
11
152
0.72
0.44
1.5
1.5
53.43
53.82
ug/l
0.02
11
152
84
753
1.12
0.44
1.2
1.2
58.00
33.43
u/ml
—
6
32
71
633
1.12
0.41
1.1
1.1
—
—
—
0
0
71
633
1.12
0.41
1.1
1.1
—
—
—
0
0
324
3085
1.06
0.41
4.6
4.7
225.89
245.41
u/l
2.82
312
2938
0
15
0.00
0.41
0.0
4.9
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
9.33
—
0
9
82
738
1.11
0.41
1.6
1.9
—
—
—
0
0
45
389
1.16
0.40
1.2
1.2
3.77
4.71
u/ml
0.21
26
173
187
1995
0.93
0.40
4.1
4.3
1.23
1.23
mmol/l
0.43
170
1739
69
616
1.12
0.40
2.2
3.0
30.87
37.24
umol/l
1.72
63
558
68
607
1.12
0.39
1.1
1.1
5.31
3.35
—
9
81
57
503
1.14
0.39
2.9
3.6
31.45
27.48
mg/l
0.21
30
343
66
589
1.12
0.38
1.8
1.4
302.67
858.37
e6/l
1.02
58
460
20
160
1.25
0.38
1.3
1.4
—
700.83
—
0
12
95
866
1.10
0.38
1.2
1.2
1.50
1.51
g/l
0.06
95
866
34
289
1.18
0.38
1.3
1.6
63.31
61.12
%
0.11
16
182
87
956
0.91
0.37
3.3
2.6
0.31
1.10
g/l
3.74
78
825
65
581
1.12
0.37
1.7
1.4
16.04
36.99
e6/l
0.61
52
433
67
600
1.12
0.37
1.6
1.5
—
—
—
0
0
16
125
1.28
0.37
1.1
1.1
1371.69
1514.03
miu/ml
0.25
16
125
451
4348
1.04
0.36
2.6
2.7
12.80
13.11
umol/l
0.44
429
4082
240
2527
0.94
0.35
2.1
2.1
3.56
3.57
ratio
0.03
190
2011
14
108
1.30
0.35
1.2
1.3
149.93
176.21
mmol/24h
0.81
14
108
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
14
108
1.30
0.35
1.0
2.2
169.21
158.77
%
0.13
14
103
24
199
1.21
0.35
1.2
1.1
—
—
—
0
0
10
134
0.75
0.35
11.0
12.5
0.56
0.62
mmol/l
—
10
125
65
585
1.11
0.34
1.2
1.2
20.38
4.06
u/ml
—
6
34
79
720
1.10
0.33
1.3
1.2
1.79
8.18
u/ml
—
9
99
17
136
1.25
0.33
6.4
6.9
39.62
161.32
ug/l
—
9
82
88
808
1.09
0.32
1.2
1.1
0.68
0.65
ratio
0.27
16
109
24
201
1.20
0.32
1.2
1.5
15.04
13.14
umol/l
0.40
19
187
391
3771
1.04
0.32
2.6
2.8
21.87
23.00
%
1.07
372
3540
54
602
0.89
0.32
1.4
1.6
—
—
—
0
0
22
183
1.20
0.31
4.6
2.7
28.65
31.83
mg/l
0.12
17
135
50
446
1.12
0.31
1.7
2.0
5.33
4.99
mmol/24h
0.23
43
399
24
202
1.19
0.31
2.5
2.4
716.53
652.11
ml
0.45
17
131
74
809
0.91
0.31
3.2
2.4
0.00
0.02
g/l
1.81
69
729
15
186
0.81
0.31
1.3
1.6
—
—
—
0
0
17
138
1.23
0.30
1.3
1.2
54.08
85.70
u/l
3.29
12
117
12
93
1.29
0.30
1.7
2.2
2.52
1.77
ratio
0.76
12
88
32
278
1.15
0.29
5.1
4.2
—
—
—
0
0
119
1113
1.07
0.29
2.2
1.8
0.46
0.33
mg/l
0.92
43
552
78
717
1.09
0.29
1.2
1.2
2.70
3.03
u/ml
—
8
60
17
139
1.22
0.29
1.2
1.1
—
—
—
0
0
8
110
0.73
0.28
1.0
1.7
39.50
40.17
g/l
—
8
110
361
3488
1.04
0.28
6.0
6.5
1.04
1.03
mmol/l
0.12
339
3264
98
913
1.08
0.27
3.9
3.8
24.80
24.88
mmol/l
0.12
92
855
15
183
0.82
0.27
1.6
1.7
—
—
—
0
0
313
3018
1.04
0.27
5.4
5.0
30.75
31.98
%
1.34
202
2010
214
2234
0.95
0.26
2.7
2.8
66.36
66.52
g/l
0.12
200
2070
175
1836
0.95
0.25
1.8
1.8
3.51
3.48
mmol/l
0.10
126
1307
53
482
1.10
0.25
2.4
2.2
2262.88
4186.31
u/l
0.36
21
185
9
74
1.22
0.25
1.4
1.7
9.04
8.08
mmol/l
—
9
74
68
736
0.92
0.25
1.6
1.8
—
—
—
0
0
10
78
1.28
0.24
1.3
1.6
80.70
513.08
nmol/24h
—
10
78
6
82
0.73
0.24
2.7
2.5
0.62
1.08
ug/l
—
6
74
100
939
1.07
0.24
2.9
2.7
—
—
—
0
0
53
579
0.91
0.24
1.5
1.5
—
—
—
0
0
23
265
0.87
0.24
1.3
1.1
—
54.73
—
0
15
20
233
0.86
0.23
1.5
1.7
—
—
—
0
0
12
97
1.24
0.23
1.1
2.3
2103.01
103.12
ug/l
0.45
12
84
10
79
1.27
0.22
1.1
1.0
—
—
—
0
0
14
116
1.21
0.22
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
135
0.81
0.22
1.4
1.1
—
—
—
0
0
13
107
1.22
0.21
1.5
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
73
682
1.07
0.21
3.0
3.4
1.84
1.84
index
0.00
32
357
20
173
1.16
0.21
1.6
1.5
—
—
—
0
0
11
89
1.24
0.21
1.5
1.3
72.91
134.32
nmol/l
2.06
11
68
23
261
0.88
0.20
1.2
1.5
—
—
—
0
0
6
49
1.22
0.20
1.2
1.0
35.87
50.26
iu/ml
—
6
49
76
809
0.94
0.19
1.8
1.7
—
—
—
0
0
61
569
1.07
0.19
3.5
6.1
82.63
577.88
iu/ml
—
8
81
117
1117
1.05
0.18
1.8
2.0
6.05
2.05
ug/l
0.75
103
1003
13
153
0.85
0.18
1.2
1.1
—
—
—
0
0
62
661
0.94
0.17
1.5
1.4
—
—
—
0
0
43
397
1.08
0.17
1.3
1.2
2.50
3.45
u/ml
0.30
14
137
5
67
0.75
0.17
1.2
1.1
—
—
—
0
0
34
370
0.92
0.16
2.2
2.7
22.38
189.93
u/ml
0.82
34
362
99
1036
0.95
0.16
2.9
2.4
2.97
2.91
g/l
0.25
90
951
11
130
0.85
0.16
1.0
1.6
—
—
—
0
0
11
130
0.85
0.16
1.0
1.6
—
—
—
0
0
54
506
1.07
0.15
1.2
1.3
13.44
37.24
u/l
3.25
45
434
6
76
0.79
0.15
1.0
1.3
—
—
—
0
0
6
80
0.75
0.15
1.2
1.1
—
—
—
0
0
10
119
0.84
0.15
1.3
1.1
—
—
—
0
0
33
303
1.09
0.15
1.3
1.4
—
—
—
0
0
14
121
1.16
0.15
4.1
3.8
—
—
—
0
0
20
179
1.12
0.14
1.2
1.1
—
—
—
0
0
19
212
0.90
0.14
1.2
1.5
167.86
206.38
pmol/l
0.37
19
212
21
189
1.11
0.13
1.2
1.1
—
—
—
0
0
21
189
1.11
0.13
1.2
1.1
—
—
—
0
0
105
1010
1.04
0.13
1.8
1.7
7.52
7.35
iu/ml
0.03
24
239
16
180
0.89
0.13
1.2
1.2
—
—
—
0
0
36
386
0.93
0.12
1.1
1.1
—
—
—
0
0
16
142
1.13
0.12
1.1
1.2
—
—
—
0
0
28
258
1.09
0.12
1.2
1.2
—
—
—
0
0
44
414
1.06
0.12
1.2
1.1
5.04
1475.56
iu/ml
—
8
89
33
307
1.08
0.12
1.3
1.4
—
—
—
0
0
23
210
1.10
0.12
1.3
1.2
2.76
2.11
mmol/l
0.93
23
198
50
528
0.95
0.12
1.3
1.5
—
—
—
0
0
27
292
0.92
0.11
1.0
1.0
2.14
2.08
eliau/ml
—
8
122
11
95
1.16
0.11
6.4
2.0
—
—
—
0
0
11
95
1.16
0.11
2.5
2.6
0.63
0.61
mmol/l
0.33
11
95
66
631
1.05
0.11
1.5
1.3
166.36
209.36
miu/ml
0.38
26
264
33
308
1.07
0.11
1.3
1.4
—
—
—
0
0
106
1096
0.97
0.11
2.8
2.4
7.67
7.35
g/l
1.22
98
1009
106
1096
0.97
0.11
2.8
2.4
4.38
4.19
g/l
2.00
98
1011
106
1095
0.97
0.11
2.8
2.4
3.68
3.73
g/l
0.16
97
1010
78
811
0.96
0.11
1.5
1.6
0.10
9.37
iu/ml
0.50
13
131
32
299
1.07
0.10
1.2
1.5
0.23
0.30
nmol/l
0.69
25
223
20
183
1.09
0.10
1.3
1.1
—
—
—
0
0
76
732
1.04
0.10
1.6
1.4
—
—
—
0
0
38
359
1.06
0.09
1.3
1.1
—
—
—
0
0
15
135
1.11
0.09
1.0
2.5
698.27
1088.74
u/ml
0.75
15
135
91
940
0.97
0.09
3.0
2.5
9.69
10.26
g/l
0.83
82
851
22
203
1.08
0.09
1.5
1.3
1.14
1.20
u/ml
0.02
12
115
10
114
0.88
0.09
1.2
1.1
—
—
—
0
0
46
439
1.05
0.08
2.3
3.8
1.41
1.53
%
0.07
41
397
16
175
0.91
0.08
2.1
1.5
76.94
85.12
umol/l
0.99
16
175
6
58
1.03
0.08
1.3
1.2
—
—
—
0
0
6
58
1.03
0.08
3.0
2.8
4.50
64.77
ug/l
—
6
58
41
430
0.95
0.08
1.2
1.5
—
—
—
0
0
81
785
1.03
0.08
1.2
1.3
—
—
—
0
0
17
185
0.92
0.08
1.1
1.2
—
—
—
0
0
251
2549
0.98
0.08
2.1
2.3
0.21
0.21
g/l
0.21
231
2381
7
64
1.09
0.08
5.0
7.7
5.51
5.37
kpa
—
7
64
14
154
0.91
0.08
1.7
1.6
—
—
—
0
0
310
3060
1.01
0.07
1.9
1.8
1.50
1.51
%
0.06
266
2684
6
72
0.83
0.07
1.2
1.1
—
—
—
0
0
6
73
0.82
0.07
1.0
1.2
—
—
—
0
0
71
688
1.03
0.07
1.2
1.7
—
—
—
0
0
14
153
0.91
0.07
1.1
1.2
146.64
137.01
nmol/l
0.28
14
153
79
811
0.97
0.06
4.3
3.7
1.38
3.04
ratio
1.61
43
467
24
254
0.94
0.06
1.0
1.1
—
—
—
0
0
89
909
0.98
0.05
4.2
3.9
97.34
76.18
mg/l
0.15
75
777
16
171
0.94
0.05
1.7
2.5
0.62
0.69
e9/l
0.31
16
163
96
942
1.02
0.05
1.2
1.2
0.37
0.79
u/ml
—
7
70
14
150
0.93
0.04
1.2
1.9
—
—
—
0
0
72
705
1.02
0.04
1.2
1.7
—
—
—
0
0
12
111
1.08
0.04
1.3
1.2
6.42
9.49
mm/h
1.14
12
111
41
398
1.03
0.04
1.2
1.2
—
—
—
0
0
22
229
0.96
0.02
1.1
1.8
—
—
—
0
0
22
229
0.96
0.02
1.1
1.8
—
—
—
0
0
22
229
0.96
0.02
1.1
1.8
—
—
—
0
0
24
231
1.04
0.02
1.2
1.2
—
—
—
0
0
110
1113
0.99
0.02
1.5
1.9
40.21
38.88
u/l
0.37
102
991
131
1297
1.01
0.02
1.4
1.5
—
—
—
0
0
62
610
1.02
0.02
1.3
1.5
—
—
—
0
0
290
2913
0.99
0.02
1.4
1.5
—
—
—
0
0
55
558
0.99
0.01
1.1
1.1
1.04
4.15
eliau/ml
—
5
64
29
297
0.98
0.01
1.9
2.3
37.80
20.19
mg/l
—
10
114
90
908
0.99
0.01
4.1
3.9
41.58
59.29
mg/l
1.29
75
775
30
294
1.02
0.00
1.3
1.4
—
—
—
0
0
30
294
1.02
0.00
1.3
1.4
—
—
—
0
0
16
161
0.99
0.00
2.0
2.3
7.27
8.18
mmol/l
0.67
16
161
30
295
1.02
0.00
1.3
1.4
—
—
—
0
0
30
301
1.00
0.00
1.3
2.0
—
1040.00
—
0
12
12
116
1.03
0.00
2.2
2.3
—
—
—
0
0
21
206
1.02
0.00
1.0
1.0
790.18
729.92
ng/l
0.20
11
136
21
206
1.02
0.00
1.0
1.0
289.50
307.35
ng/l
0.18
14
139
23
226
1.02
0.00
1.0
1.3
—
—
—
0
0
23
226
1.02
0.00
1.2
1.1
—
—
—
0
0
10
98
1.02
0.00
1.3
1.0
—
—
—
0
0
21
208
1.01
0.00
1.0
1.5
1.39
1.19
promille
0.25
16
165
21
208
1.01
0.00
1.0
1.0
35.37
42.38
ng/l
0.50
14
136
10
97
1.03
0.00
1.0
1.1
—
—
—
0
0
11
107
1.03
0.00
1.5
1.3
—
—
—
0
0
18
177
1.02
0.00
1.4
1.5
12.50
13.27
u/l
0.23
18
169
23
233
0.99
0.00
3.3
3.4
13.92
11.39
index
0.49
12
135
17
173
0.98
0.00
1.1
1.1
—
—
—
0
0
9
97
0.93
0.00
1.3
2.3
—
—
—
0
0
7
72
0.97
0.00
1.1
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
1.28
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
-0.00
2.4
1.7
—
—
—
0
0
7
75
0.93
-0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
65
0.92
-0.00
1.2
1.5
15.67
15.67
pmol/l
—
6
56
9
95
0.95
-0.00
1.2
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
-0.00
1.4
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.3
—
—
—
0
0
13
130
1.00
-0.00
1.2
2.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
-0.00
5.0
7.6
5.81
5.98
kpa
—
7
64
13
130
1.00
-0.00
1.2
2.1
—
—
—
0
0
9
93
0.97
-0.00
1.0
1.6
—
—
—
0
0
9
95
0.95
-0.00
1.2
2.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
7.2
—
79.00
—
0
6
13
130
1.00
-0.00
1.2
2.1
—
—
—
0
0
13
130
1.00
-0.00
1.2
2.1
—
—
—
0
0
7
73
0.96
-0.00
1.1
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_LIPO_SKIN_HEADFACENECK and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_LIPO_SKIN_HEADFACENECK | 0.978 [0.87, 1.09] | 0.695 |
| Birth year | 0.993 [0.99, 1.0] | 0.116 |
During the follow-up period (1.1.1998 — 31.12.2019), 693 out of 6575 females with CD2_BENIGN_LIPO_SKIN_HEADFACENECK died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_LIPO_SKIN_HEADFACENECK | 1.012 [0.91, 1.13] | 0.832 |
| Birth year | 0.985 [0.98, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1221 out of 8836 males with CD2_BENIGN_LIPO_SKIN_HEADFACENECK died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_LIPO_SKIN_HEADFACENECK.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.086% | 0.145% |
| 5 | 0.476% | 1.003% |
| 10 | 1.341% | 2.612% |
| 15 | 2.47% | 4.84% |
| 20 | 4.234% | 8.152% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LIPO_SKIN_HEADFACENECK – Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data